HC Wainwright Forecasts Lipocine’s Q3 Earnings (NASDAQ:LPCN)

Lipocine Inc. (NASDAQ:LPCN – Free Report) – Analysts at HC Wainwright decreased their Q3 2025 earnings per share estimates for shares of Lipocine in a research report issued on Wednesday, August 20th. HC Wainwright analyst Y. Chen now expects that the specialty pharmaceutical company will earn ($0.56) per share for the quarter, down from their […]

Leave a Reply

Your email address will not be published.

Previous post State Fair Grandstand review: Meghan Trainor hosts an enjoyable dance party sans band
Next post HC Wainwright Forecasts Reduced Earnings for Defiance Silver